Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Intelligent Health aim to get the whole community active by providing games and incentives such as ''beat the street''. By providing schools and communities with friendly competition to walk and cycle more by tapping their cards on ''beat boxes'', and with prizes and league tables on offer, Intelligent health are bringing communities together.
days to go:
Expired
investment:
£700,000
Propio offers The Property ISA, a tax-efficient, simple and affordable way to invest in properties. The company aims to become the UK’s largest property-based ISA by making the experience of investing as straightforward as online shopping. Propio is powered by a team of property and finance heavyweights who hand-select all the investments, helping the customers reduce risks and earn stable, tax-free returns, irrespective of market fluctuation. The company’s client base comprises 1000+ customers who have invested over £7.5m in it. According to TrustPilot, Propio is among the top 10 investment companies in the UK, delivering average returns of 6.5% to investors, despite Brexit and stock market turmoil. Moreover, the company has partnered with two UK finance and property firms and expects an investment deal flow of up to £100m by 2021-22.
days to go:
Expired
investment:
£357,660
AAZZUR is a fintechs company founded on a strong desire to make banking intelligent, individual and interconnected. It is reinventing the way banks are built, and its data can be used to increase monetization, satisfaction and retention. This company was founded 18 months ago, but in the last month, it was contacted by fintechs, banks and one insurance company to help them with their problems. AAZZUR provides tools for common functions for the banking space. Its entrepreneurial team has a depth of experience, and the company has been to one of the world-leading accelerators, techstars. Now, it is looking to work together with banks, and its team has developed a neo-bank offering in record time that they are going to be soft-launched soon.
days to go:
Expired
investment:
£400,991
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go:
Expired
investment:
£3,768,260
Legal Connection (LC) is on a mission to democratise the $1 trillion legal profession, and enabling networks of legal professionals to compete with large partnership firms. The company asserts that the UK leads the world in being a friendly regulatory environment for freelance lawyers and virtual firms. LC aims to capture this sentiment and provide the aforementioned lawyers with the right technology so that they can group to provide a comparable service to large firms at a fraction of the price. LC argues that its product looks like a social networking tool but functions as a legal case and practise management suite wherein all the work takes place in secure chat rooms. Lawyers are also allowed to leverage third-party managed accounts to hold client money and execute transactions. LC was selected by Antler Venture Capital and given a pre-seed investment of £120,000. LC will use the investment to grow its user base, continue product development, and use technology to power the future of law.
days to go:
Expired
investment:
£211,874
